Comprehensive Report on the Nuclear Medicine Market: Opportunities and Challenges

 By combining trend forecasting and competitive intelligence, this report supports future-focused strategy in the nuclear medicine sector.

 

 What Is The Expected CAGR For The Nuclear Medicine Market Through 2025?
 The nuclear medicine market size has grown rapidly in recent years. It will grow from $8.93 billion in 2024 to $10.18 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to aging population, cancer diagnosis and staging, cardiology applications, neurological disorders, regulatory approvals.
 
 The nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $15.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to personalized medicine, oncology and neurology research, sustainable practices, research and development, telemedicine services. Major trends in the forecast period include radioimmunotherapy, hybrid imaging, artificial intelligence (AI), emerging radiopharmaceuticals, diagnostic imaging advancements.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp
 
 Which Key Factors Will Influence Nuclear Medicine Market Growth Over 2025–2034?
 The increase in constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel disorders, and cancer is a disease in which cells grow out of control and spread to other body parts. Nuclear cardiac imaging can help diagnose cardiac diseases more quickly. Nuclear medicine therapy is a method to treat cancer that might be used with or after other therapy options, such as surgery and chemotherapy. As a result, the growing constancy and prevalence of cardiovascular disease and cancer increases the demand for nuclear medicine market. For instance, in January 2023, according to the American Cancer Society Inc., a US-based non-profit health group, in 2023, 1,958,310 new cancer cases are expected to be diagnosed in the US, an increase compared to more than 1,918,030 new cancer cases in 2022. Therefore, the growing constancy and prevalence of cardiovascular diseases and cancer are driving the nuclear medicine market.
 
 Comprehensive Segment-Wise Insights Into The Nuclear Medicine Market
 The nuclear medicinemarket covered in this report is segmented — 
 
 1) By Type: Diagnostic; Therapeutic
 2) By Application: Cardiology; Lymphoma; Thyroid; Neurology; Oncology; Other Application
 3) By End-User: Hospitals and Clinics; Diagnostic Centers; Other End Users
 
 Subsegments:
 1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Gamma Cameras; Radiopharmaceuticals for Imaging; Other Diagnostic Imaging Techniques
 2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy; Beta Emitters; Alpha Emitters; Radiosynovectomy Agents; Other Therapeutic Applications
 
 What Are The Prominent Trends In The Nuclear Medicine Market?
 Major companies operating in the nuclear medicine market are focusing on developing innovative solutions, such as nuclear medicine cyclotrons, to enhance the production of radiopharmaceuticals and improve diagnostic imaging capabilities. Nuclear medicine Cyclotrons are specialized particle accelerators that produce radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals used in procedures like positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, launched its first batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are crucial for nuclear medicine, enabling the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, enhancing capabilities in early disease detection and personalized treatment.
 
 Analysis Of Key Players In Nuclear Medicine Market
 Major companies operating in the nuclear medicine market include Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Medtronic plc, Triad Isotopes Inc., FUJIFILM Holdings Corporation, Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., Global Medical Solutions LLC, Charles River Analytics Inc., Touchlight Genetics Ltd., Numares B.V., Tech-X Corporation, Karyopharm Therapeutics Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC 
 
 View the full nuclear medicine market report here:
 https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
 
 What Are The Key Regional Trends In The Nuclear Medicine Market?
 North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company